Home 2026 [www.proximacro.com]
Proxima provides regulatory, quality & clinical trial life science solutions to the new class of rising stars in drugs, devices, diagnostics & digital therapeutics
Proxima Raises $80 Million Led by DCVC to Power the Next …
4 days ago · Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity therapeutics, today announced an oversubscribed $80M seed …
Proxima raises $80 million for AI drug discovery from DCVC, Nvidia
Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding, which will help it collect better data and ...
AI biotech Proxima raises $80M from DCVC and NVentures for …
4 days ago · New York-based biotech startup Proxima has emerged from stealth with $80 million seed funding to reshape how medicines influence cells.
Proxima Raises $80 Million to Advance AI-Driven Proximity-Based …
5 days ago · BOSTON, Mass. — Proxima, an AI-native biotechnology company focused on proximity-based medicines, said it has raised $80 million in an oversubscribed seed financing round to …
Proxima $80M funding fuels AI drug design for proximity therapeutics
4 days ago · Proxima secured $80 million in funding led by DCVC and NVentures to advance its AI platform for designing next generation proximity-based medicines.
Proxima Closes $80M Seed Round to Advance Quest for ‘Proximity’ …
4 days ago · New York-based Proxima (formerly VantAI), an AI-native biotech company focused on so-called proximity therapeutics, has closed an oversubscribed $80 million seed round led by DCVC, …
Proxima Raises $80 Million Led by DCVC to Power the Next ... - BioSpace
4 days ago · NEW YORK & BOSTON-- (BUSINESS WIRE)-- #AI -- Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity …
Proxima lands $80m to make protein interactions programmable
3 days ago · AI-native biotech Proxima has raised $80 million in an oversubscribed seed round to advance new medicines designed to control how proteins interact with one another. Previously …
Proxima | Specialist Procurement & Supply Chain Consultants
We are Proxima, a global procurement and supply chain consultancy that is part of the Bain procurement ecosystem. We work alongside some of the world’s largest and most successful …